We are live on ! Find out more
RCM

Raleigh Capital Management Portfolio holdings

AUM $313M
1-Year Est. Return 23.55%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+23.55%
3 Year Est. Return
+71.82%
5 Year Est. Return
10 Year Est. Return
AUM
$192M
AUM Growth
+$21.2M
Cap. Flow
+$5.43M
Cap. Flow %
2.82%
Top 10 Hldgs %
19.8%
Holding
915
New
76
Increased
369
Reduced
163
Closed
149

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$1.01M
2
CVX icon
Chevron
CVX
+$861K
3
XOM icon
ExxonMobil
XOM
+$817K
4
BMY icon
Bristol-Myers Squibb
BMY
+$696K
5
MRK icon
Merck
MRK
+$685K

Sector Composition

Rank Sector Weight
1 Financials 10.54%
2 Healthcare 10.29%
3 Consumer Staples 9.47%
4 Energy 7.21%
5 Utilities 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGC
551
Canopy Growth
CGC
$410M
$4.98K ﹤0.01%
+216
New +$6.66K
AZZ icon
552
AZZ Inc
AZZ
$4.54B
$4.95K ﹤0.01%
123
+83
+208% +$3.26K
TTMI icon
553
TTM Technologies
TTMI
$14.5B
$4.95K ﹤0.01%
328
+168
+105% +$2.49K
FBNC icon
554
First Bancorp
FBNC
$2.68B
$4.89K ﹤0.01%
114
+83
+268% +$3.64K
SNOW icon
555
Snowflake
SNOW
$115B
$4.88K ﹤0.01%
34
+13
+62% +$1.98K
CHCO icon
556
City Holding Co
CHCO
$2.04B
$4.86K ﹤0.01%
52
+31
+148% +$2.98K
FG icon
557
F&G Annuities & Life
FG
$3.62B
$4.82K ﹤0.01%
+241
New +$4.91K
SPDV icon
558
AAM S&P 500 High Dividend Value ETF
SPDV
$102M
$4.76K ﹤0.01%
163
+1
+0.6% +$29
EXPE icon
559
Expedia Group
EXPE
$37.3B
$4.73K ﹤0.01%
54
+18
+50% +$1.7K
CMI icon
560
Cummins
CMI
$88.7B
$4.54K ﹤0.01%
19
-1
-5% -$238
GRX
561
Gabelli Healthcare & Wellness Trust
GRX
$146M
$4.54K ﹤0.01%
442
+6
+1% +$60
NVS icon
562
Novartis
NVS
$297B
$4.54K ﹤0.01%
50
-41
-45% -$3.45K
SWAV
563
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$4.52K ﹤0.01%
22
+9
+69% +$2.28K
EOG icon
564
EOG Resources
EOG
$70.7B
$4.5K ﹤0.01%
35
+4
+13% +$532
MAR icon
565
Marriott International
MAR
$92.3B
$4.47K ﹤0.01%
+30
New +$4.62K
NBIX icon
566
Neurocrine Biosciences
NBIX
$16.6B
$4.42K ﹤0.01%
37
+10
+37% +$1.17K
CIM
567
Chimera Investment
CIM
$1B
$4.4K ﹤0.01%
267
GEO icon
568
The GEO Group
GEO
$4.04B
$4.3K ﹤0.01%
393
+235
+149% +$2.29K
AAON icon
569
Aaon
AAON
$7.77B
$4.3K ﹤0.01%
86
+39
+83% +$1.82K
IYH icon
570
iShares US Healthcare ETF
IYH
$3.71B
$4.27K ﹤0.01%
75
NIC icon
571
Nicolet Bankshares
NIC
$3.62B
$4.23K ﹤0.01%
53
+24
+83% +$1.87K
HP icon
572
Helmerich & Payne
HP
$3.71B
$4.13K ﹤0.01%
+83
New +$3.95K
FULT icon
573
Fulton Financial
FULT
$4.64B
$4.11K ﹤0.01%
244
+113
+86% +$1.98K
ALKS icon
574
Alkermes
ALKS
$8.25B
$4.05K ﹤0.01%
155
+68
+78% +$1.63K
PEB icon
575
Pebblebrook Hotel Trust
PEB
$2.05B
$4.04K ﹤0.01%
302
+128
+74% +$1.96K

Similar funds

Raleigh Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Raleigh Capital Management held 915 positions worth $192M, up 12% from $171M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raleigh Capital Management's Q4 2022 filing shows 76 new, 369 increased, 163 reduced and 149 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 13,550 shares worth $1.36M. The largest sale was Amgen, an estimated $1.01M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Raleigh Capital Management's largest Q4 2022 buy was iShares 0-3 Month Treasury Bond ETF: 13,550 shares worth $1.36M.
  • Raleigh Capital Management added most to Medtronic in Q4 2022, an estimated $1.02M increase.
  • Raleigh Capital Management's biggest Q4 2022 reduction was Amgen, cutting an estimated $1.01M.
  • Raleigh Capital Management fully exited iShares Core High Dividend ETF in Q4 2022, selling an estimated $454K.
  • Raleigh Capital Management's ten largest holdings make up 20% of its $192M portfolio in Q4 2022.
  • Raleigh Capital Management opened 76 new positions and closed 149 in Q4 2022.
  • Raleigh Capital Management's portfolio value rose 12% quarter-over-quarter to $192M.

Based on Raleigh Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.